CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,250 shares at an average $28.56 ($178,485)
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale CHIEF OPERATING OFFICER sold 716 shares at $30.00 ($21,483)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 847 shares at $30.00 ($25,413)
- 4 Planned sale PRESIDENT AND CEO sold 924 shares at $30.00 ($27,723)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 814 shares at $30.00 ($24,422)
- 4 Planned sale Director sold 1,570 shares at an average $30.00 ($47,104)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 816 shares at $30.00 ($24,482)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 15 of 40 · 798 filings